|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
|
Ross (Michigan)
Full Time MBA |
Admitted, ($$)
|
Round 2 | 2024 | 730 GMAT Classic | 3.3 | 4 | Finance | China |
12 Mar 2024 10:47 PM
|
|
Ross (Michigan)
Full Time MBA |
Admitted, ($$)
|
Round 2 | 2024 | 685 GMAT Focus 650 GMAT Classic 710 GMAT Classic 710 GMAT Classic |
3.5 | 10 | Consulting | China |
12 Mar 2024 09:48 PM
|
|
IESE
Full Time MBA |
Admitted
|
Round 2 | 2024 | 645 GMAT Focus | 3 | 6 | Finance | India |
12 Mar 2024 08:33 PM
|
|
Ross (Michigan)
Full Time MBA |
Admitted, ($)
|
Round 2 | 2024 | 330 GRE | 3.4 | 5 | Technology | India |
12 Mar 2024 08:25 PM
|
|
HEC Paris
September Intake |
Interviewed
|
Round 6 | 2024 | 0 | Consulting | Singapore |
12 Mar 2024 07:46 PM
|
||
|
Owen Vanderbilt
Full Time MBA |
Admitted
|
Round 2 | 2024 | 625 GMAT Focus | 4 | Finance | United States |
12 Mar 2024 06:44 PM
|
|
|
Kenan-Flagler
Full Time MBA |
Denied with Interview
|
Round 2 | 2024 | 625 GMAT Focus | 4 | Finance | United States |
12 Mar 2024 06:44 PM
|
|
|
LBS
Full Time MBA |
Denied with Interview
|
Round 1 | 2024 | 325 GRE | 3.9 | 0 | Healthcare/Pharmaceuticals | India |
12 Mar 2024 06:43 PM
|
|
Darden
Full Time MBA |
Denied with Interview
|
Round 1 | 2024 | 325 GRE | 3.9 | 0 | Healthcare/Pharmaceuticals | India |
12 Mar 2024 06:43 PM
|
|
Darden
Full Time MBA |
Admitted, ($$$$)
|
Round 2 | 2024 | 314 GRE | 3.2 | 3 | Finance: Private Equity | Dominican Republic |
12 Mar 2024 06:33 PM
|
|
Darden
Full Time MBA |
Admitted
|
Round 2 | 2024 | 750 GMAT Classic | 3.5 | 4 | Finance: Investment Banking | United States |
12 Mar 2024 04:00 PM
|
|
Darden
Full Time MBA |
Admitted, ($$$$)
|
Round 2 | 2024 | Waiver | 3.7 | 8 | Technology | United States |
12 Mar 2024 03:56 PM
|
|
Harvard
Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 325 GRE | 3.9 | 4 | Consulting | Nigeria |
12 Mar 2024 02:07 PM
|
|
Columbia
Full Time MBA |
Waitlisted without Interview
|
Round 2 | 2024 | 320 GRE | 3.4 | 4 | Finance: Investment Banking | United States |
12 Mar 2024 01:18 PM
|
|
Fuqua
Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | 325 GRE | 8 | Healthcare/Pharmaceuticals | South Africa |
12 Mar 2024 12:58 PM
|
|
|
Fuqua
Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | 690 GMAT Classic 750 GMAT Classic |
3.5 | 10 | Consulting | United States |
12 Mar 2024 12:54 PM
|
|
Tuck
Full Time MBA |
Interviewed
|
Round 2 | 2024 | 735 GMAT Focus | 3.9 | 3 | Consulting | United States |
12 Mar 2024 12:34 PM
|
|
Sloan MIT
Full Time MBA |
Denied without Interview
|
Round 2 | 2024 | 735 GMAT Focus | 3.9 | 3 | Consulting | United States |
12 Mar 2024 12:34 PM
|
|
Fuqua
Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2024 | 735 GMAT Focus | 3.9 | 3 | Consulting | United States |
12 Mar 2024 12:34 PM
|
|
Kenan-Flagler
Full Time MBA |
Admitted, ($)
|
Round 2 | 2024 | 720 GMAT Classic | 3 | 4 | Technology | India |
12 Mar 2024 12:25 PM
|